Which companies are Sahajanand Medical Technologies's closest peers?

The cockpit's peer set: Myriad Genetics (MYGN), Guangdong Hybribio Biotech (300639.SZ), Anbio Biotechnology (NNNN), Zhejiang Orient Gene Biotech (688298.SS), MedicalSystem Biotechnology (300439.SZ), Sight Sciences (SGHT), Anteris Technologies Global (AVR), Zhejiang Gongdong Medical Technology (605369.SS).

← CockpitCompetitor Analysis › SMT.NS Sahajanand Medical Technologies LimitedOpen in the cockpit ↗

Sahajanand Medical Technologies LimitedSMT.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Medical Specialties

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$566M

US dollars, full cap

$/day

$23.7M

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

n/a

Hurdle

n/a

no reverse DCF

Close · INR₹525.95

1D+7.8%

1W+13.7%

1Mn/a

3Mn/a

6Mn/a

YTDn/a

1Yn/a

What Sahajanand Medical Technologies does

No business profile yet.

Sahajanand Medical Technologies at a glance

Size Sahajanand Medical Technologies (SMT.NS) is an India Health Care company (Medical Specialties) with a market value of $566M, the 794th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹525.95 on 6 Nov 2026.

Sahajanand Medical Technologies financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue growth	—	—	—	—	—

Quarterly statements and history in the cockpit →

Sahajanand Medical Technologies competitors and peer comparison

How Sahajanand Medical Technologies compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
Sahajanand Medical Technologies SMT.NS	India	$566M	n/a	n/a	n/a	n/a	n/a	n/a
Myriad Genetics MYGN	United States	$566M	+38%	-3%	-11%	0.8×	n/a	n/a
Guangdong Hybribio Biotech 300639.SZ	China	$568M	-5%	-7%	4%	4.5×	2.7%	-13.2%
Anbio Biotechnology NNNN	United States	$560M	-85%	+10%	67%	n/a	n/a	n/a
Zhejiang Orient Gene Biotech 688298.SS	China	$559M	-17%	+18%	-60%	2.0×	n/a	n/a
MedicalSystem Biotechnology 300439.SZ	China	$556M	-4%	+14%	2%	1.7×	7.4%	-7.8%
Sight Sciences SGHT	United States	$555M	-14%	+9%	-33%	6.2×	n/a	n/a
Anteris Technologies Global AVR	United States	$555M	-14%	-10%	-4,738%	134.2×	n/a	n/a
Zhejiang Gongdong Medical Technology 605369.SS	China	$581M	-10%	+6%	9%	2.8×	11.6%	+6.5%
Nanjing Vishee Medical Technology 688580.SS	China	$550M	-40%	+7%	24%	6.0×	22.3%	+4.2%
Tactile Systems Technology TCMD	United States	$583M	+1%	+14%	9%	1.5×	7.8%	+12.0%
Medprin Regenerative Medical Technologies 301033.SZ	China	$542M	-3%	+23%	31%	8.0×	6.3%	+24.4%
Assure Tech (Hangzhou) 688075.SS	China	$538M	-25%	-21%	-7%	n/a	n/a	n/a
Zhejiang Starry Pharmaceutical 603520.SS	China	$537M	-32%	+9%	3%	2.3×	n/a	n/a
medmix MEDX.SW	Switzerland	$537M	+24%	-7%	6%	1.5×	5.0%	+5.0%
Nanosonics NAN.AX	Australia	$599M	-13%	+3%	7%	3.6×	34.4%	+6.7%
Contec Medical Systems 300869.SZ	China	$600M	-23%	-2%	-16%	6.3×	17.3%	-19.8%
Medistim MEDI.OL	Norway	$601M	+30%	+19%	29%	6.8×	-1.8%	+14.5%
Jin Medical International ZJYL	United States	$532M	+53%	-14%	2%	26.5×	n/a	n/a
Wuhan Huakang Century Clean Technology 301235.SZ	China	$603M	-42%	+28%	7%	1.7×	n/a	n/a
Ningbo David Medical Device 300314.SZ	China	$607M	+22%	+19%	11%	5.6×	n/a	n/a

Questions

Which companies are Sahajanand Medical Technologies's closest peers?: The cockpit's peer set: Myriad Genetics (MYGN), Guangdong Hybribio Biotech (300639.SZ), Anbio Biotechnology (NNNN), Zhejiang Orient Gene Biotech (688298.SS), MedicalSystem Biotechnology (300439.SZ), Sight Sciences (SGHT), Anteris Technologies Global (AVR), Zhejiang Gongdong Medical Technology (605369.SS).